Moreover, similar mechanisms may be operant in B-ALL with MLL translocations, and loss-of-function experiments in primary patient samples and mouse models of MLL-driven leukemia are areas for further investigation. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.